The Money Runner
Biotech in 2017
David joins CNBC anchors Bill Griffeth and Kelly Evans along with Forbes columnist Luke Timmerman to discuss prospects for the Biotech sector in 2017.
Don’t Shoot the Messenger! – Fed Chair Yellen
By David Nelson, CFA A cloud of controversy seems to have swept up the media regarding Fed Chair Yellen’s Congressional testimony where she signaled out two sectors or asset classes that she believes are showing some signs of froth. “How dare her”; voices from the crowd yelled. The morning after echoed those of a lynch […]
